• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞蛋白 C 受体,重症肺炎患者发生急性呼吸窘迫综合征的风险因素。

Endocan, a Risk Factor for Developing Acute Respiratory Distress Syndrome among Severe Pneumonia Patients.

机构信息

Department of Respiratory, Hwa Mei Hospital, University of Chinese Academy of Sciences, No. 41, Xibei Street, Ningbo 315000, Zhejiang, China.

出版信息

Can Respir J. 2019 Apr 1;2019:2476845. doi: 10.1155/2019/2476845. eCollection 2019.

DOI:10.1155/2019/2476845
PMID:31065299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6466887/
Abstract

BACKGROUND

Severe pneumonia (SP) has been widely accepted as a major cause for acute respiratory distress syndrome (ARDS), and the development of ARDS is significantly associated with increased mortality. This study aimed to identify potential predictors for ARDS development in patients with SP.

METHODS

Eligible SP patients at admission from January 2013 to June 2017 were prospectively enrolled, and ARDS development within hospital stay was identified. Risk factors for ARDS development in SP patients were analyzed by univariate and multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve analysis with the area under the curve (AUC) was performed for the predictive value of endocan for ARDS development.

RESULTS

A total of 145 SP patients were eventually enrolled into the final analysis, of which 37 developed ARDS during the hospital stay. Our final multivariate logistic regression analysis suggested plasma endocan expression as the only independent risk factor for ARDS development in SP patients (OR: 1.57, 95% CI: 1.14-2.25, =0.021). ROC curve analysis of plasma endocan resulted in an AUC of 0.754, 95% CI of 0.642-0.866, a cutoff value of 11.6 ng/mL, a sensitivity of 78.7%, and a specificity of 70.3%, respectively ( < 0.01).

CONCLUSIONS

Endocan expression at ICU admission is a reliable predictive factor in predicting ARDS in patients with SP.

摘要

背景

严重肺炎(SP)已被广泛认为是急性呼吸窘迫综合征(ARDS)的主要病因,ARDS 的发展与死亡率的增加显著相关。本研究旨在确定 SP 患者中 ARDS 发展的潜在预测因素。

方法

前瞻性纳入 2013 年 1 月至 2017 年 6 月入院的符合条件的 SP 患者,并确定住院期间 ARDS 的发展情况。采用单因素和多因素 logistic 回归分析 SP 患者 ARDS 发展的危险因素。采用受试者工作特征(ROC)曲线分析内脂素对 ARDS 发展的预测价值,并计算曲线下面积(AUC)。

结果

共纳入 145 例 SP 患者进行最终分析,其中 37 例在住院期间发生 ARDS。我们最终的多因素 logistic 回归分析表明,血浆内脂素表达是 SP 患者 ARDS 发展的唯一独立危险因素(OR:1.57,95%CI:1.14-2.25,=0.021)。血浆内脂素的 ROC 曲线分析得出 AUC 为 0.754,95%CI 为 0.642-0.866,截断值为 11.6ng/mL,灵敏度为 78.7%,特异性为 70.3%(<0.01)。

结论

入住 ICU 时的内脂素表达是预测 SP 患者 ARDS 的可靠预测因素。

相似文献

1
Endocan, a Risk Factor for Developing Acute Respiratory Distress Syndrome among Severe Pneumonia Patients.内皮细胞蛋白 C 受体,重症肺炎患者发生急性呼吸窘迫综合征的风险因素。
Can Respir J. 2019 Apr 1;2019:2476845. doi: 10.1155/2019/2476845. eCollection 2019.
2
Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.低内皮细胞水平可预测严重脓毒症和感染性休克所致急性呼吸窘迫综合征。
J Crit Care. 2018 Oct;47:121-126. doi: 10.1016/j.jcrc.2018.06.018. Epub 2018 Jun 20.
3
Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome.外周血中内脂素水平可预测急性呼吸窘迫综合征的预后。
Mediators Inflamm. 2014;2014:625180. doi: 10.1155/2014/625180. Epub 2014 Jul 16.
4
Endocan is a stable circulating molecule in ICU patients.内皮糖蛋白是重症监护病房患者体内一种稳定的循环分子。
Clin Biochem. 2017 Oct;50(15):870-877. doi: 10.1016/j.clinbiochem.2017.04.011. Epub 2017 Apr 18.
5
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.内消蛋白、脓毒症、肺炎和急性呼吸窘迫综合征。
Crit Care. 2018 Oct 26;22(1):280. doi: 10.1186/s13054-018-2222-7.
6
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts.血浆表面活性蛋白 D 作为急性呼吸窘迫综合征的诊断生物标志物:美国和韩国队列的验证。
BMC Pulm Med. 2017 Dec 15;17(1):204. doi: 10.1186/s12890-017-0532-1.
7
Acute respiratory distress syndrome in blunt trauma: identification of independent risk factors.钝性创伤所致急性呼吸窘迫综合征:独立危险因素的识别
Am Surg. 2002 Oct;68(10):845-50; discussion 850-1.
8
[Prognostic value of the dynamic changes in extra vascular lung water index and angiopoietin-2 in severe multiple trauma patients with acute respiratory distress syndrome].[血管外肺水指数及血管生成素-2动态变化对严重多发伤合并急性呼吸窘迫综合征患者的预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):571-576. doi: 10.3760/cma.j.issn.2095-4352.2019.05.010.
9
Mortality predictors in recipients developing acute respiratory distress syndrome due to pneumonia after kidney transplantation.肾移植后因肺炎发生急性呼吸窘迫综合征的受者的死亡预测因素
Ren Fail. 2016 Aug;38(7):1082-8. doi: 10.1080/0886022X.2016.1184938. Epub 2016 May 17.
10
[Risk factors analysis of acute respiratory distress syndrome in intensive care unit traumatic patients].[重症监护病房创伤患者急性呼吸窘迫综合征的危险因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Oct;30(10):978-982. doi: 10.3760/cma.j.issn.2095-4352.2018.010.015.

引用本文的文献

1
Endocan as a biomarker for acute respiratory distress syndrome: A systematic review and meta-analysis.内皮抑素作为急性呼吸窘迫综合征的生物标志物:一项系统评价和荟萃分析。
Health Sci Rep. 2024 Sep 2;7(9):e70044. doi: 10.1002/hsr2.70044. eCollection 2024 Sep.
2
Smoking on the risk of acute respiratory distress syndrome: a systematic review and meta-analysis.吸烟与急性呼吸窘迫综合征风险:系统评价和荟萃分析。
Crit Care. 2024 Apr 14;28(1):122. doi: 10.1186/s13054-024-04902-6.
3
What applications for plasma endocan measurement in intensive care? A clarification.

本文引用的文献

1
Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.低内皮细胞水平可预测严重脓毒症和感染性休克所致急性呼吸窘迫综合征。
J Crit Care. 2018 Oct;47:121-126. doi: 10.1016/j.jcrc.2018.06.018. Epub 2018 Jun 20.
2
Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan.糖萼生物标志物 syndecan-1 比内脂素更能预测因肺炎导致脓毒症的患者发生呼吸衰竭。
J Crit Care. 2018 Oct;47:93-98. doi: 10.1016/j.jcrc.2018.06.015. Epub 2018 Jun 18.
3
Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study.
血浆内脂素检测在重症监护中的应用有哪些?解读。
Crit Care. 2023 Oct 17;27(1):397. doi: 10.1186/s13054-023-04686-1.
4
Risk of Acute Respiratory Distress Syndrome in Community-Acquired Pneumonia Patients: Use of an Artificial Neural Network Model.社区获得性肺炎患者发生急性呼吸窘迫综合征的风险:人工神经网络模型的应用
Emerg Med Int. 2023 Feb 7;2023:2631779. doi: 10.1155/2023/2631779. eCollection 2023.
5
Can Serum Endocan Levels be Used as an Early Prognostic Marker for Endothelial Dysfunction in COVID-19?血清内皮细胞蛋白聚糖水平能否作为 COVID-19 内皮功能障碍的早期预后标志物?
Angiology. 2022 May;73(5):438-444. doi: 10.1177/00033197211050446. Epub 2021 Oct 18.
6
Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension.系统性硬化症女性患者体内的内脂素与循环祖细胞:与炎症及肺动脉高压的关联
Biomedicines. 2021 May 11;9(5):533. doi: 10.3390/biomedicines9050533.
7
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.雾化肝素治疗急性呼吸窘迫综合征患者或有急性呼吸窘迫综合征风险患者的多中心、随机、双盲、安慰剂对照 3 期试验。
Lancet Respir Med. 2021 Apr;9(4):360-372. doi: 10.1016/S2213-2600(20)30470-7. Epub 2021 Jan 22.
8
Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome.关于急性呼吸窘迫综合征的病理学、炎症和生物标志物的新观点。
Int J Mol Sci. 2020 Dec 28;22(1):205. doi: 10.3390/ijms22010205.
9
A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality.生物标志物与急性呼吸窘迫综合征发展和死亡率的多变量相关性的系统评价。
Crit Care. 2020 May 24;24(1):243. doi: 10.1186/s13054-020-02913-7.
重症肺炎患者中急性呼吸窘迫综合征高危患者的早期识别:一项回顾性队列研究
J Thorac Dis. 2017 Oct;9(10):3979-3995. doi: 10.21037/jtd.2017.09.20.
4
Is Endocan a Diagnostic Marker for Pneumonia After Cardiac Surgery? The ENDOLUNG Study.内脂素是否可作为心脏手术后肺炎的诊断标志物?ENDOLUNG 研究。
Ann Thorac Surg. 2018 Feb;105(2):535-541. doi: 10.1016/j.athoracsur.2017.07.031. Epub 2017 Nov 11.
5
Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome.内皮糖蛋白作为急性呼吸窘迫综合征患者严重程度的早期生物标志物。
Ann Intensive Care. 2017 Sep 7;7(1):93. doi: 10.1186/s13613-017-0311-4.
6
Extracorporeal membrane oxygenation in an HIV-positive man with severe acute respiratory distress syndrome secondary to pneumocystis and cytomegalovirus pneumonia.一名感染人类免疫缺陷病毒(HIV)的男性因肺孢子菌和巨细胞病毒性肺炎继发严重急性呼吸窘迫综合征而接受体外膜肺氧合治疗。
Int J STD AIDS. 2018 Feb;29(2):198-202. doi: 10.1177/0956462417725447. Epub 2017 Aug 13.
7
Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction.循环内Endocan 在脓毒症随访中的增加与器官功能障碍的进展有关。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1749-1756. doi: 10.1007/s10096-017-2988-6. Epub 2017 Apr 28.
8
Endocan is a stable circulating molecule in ICU patients.内皮糖蛋白是重症监护病房患者体内一种稳定的循环分子。
Clin Biochem. 2017 Oct;50(15):870-877. doi: 10.1016/j.clinbiochem.2017.04.011. Epub 2017 Apr 18.
9
Microvascular reactivity is altered early in patients with acute respiratory distress syndrome.急性呼吸窘迫综合征患者早期微血管反应性发生改变。
Respir Res. 2016 May 17;17(1):59. doi: 10.1186/s12931-016-0375-y.
10
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.